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Abstract
To understand the impact of alternative translation initiation on a
proteome, we performed a proteome-wide study on protein
turnover using positional proteomics and ribosome profiling to
distinguish between N-terminal proteoforms of individual genes.
By combining pulsed SILAC with N-terminal COFRADIC, we
monitored the stability of 1,941 human N-terminal proteoforms,
including 147 N-terminal proteoform pairs that originate from
alternative translation initiation, alternative splicing or incomplete
processing of the initiator methionine. N-terminally truncated
proteoforms were less abundant than canonical proteoforms and
often displayed altered stabilities, likely attributed to individual
protein characteristics, including intrinsic disorder, but indepen-
dent of N-terminal amino acid identity or truncation length. We
discovered that the removal of initiator methionine by methionine
aminopeptidases reduced the stability of processed proteoforms,
while susceptibility for N-terminal acetylation did not seem to
influence protein turnover rates. Taken together, our findings
reveal differences in protein stability between N-terminal proteo-
forms and point to a role for alternative translation initiation and
co-translational initiator methionine removal, next to alternative
splicing, in the overall regulation of proteome homeostasis.
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Introduction
Protein stability has been suggested to reflect the individual proper-
ties and biological functions of proteins (Cambridge et al, 2011;
Boisvert et al, 2012). In eukaryotic cells, a wide variety of proteins
with roles in cell cycle progression, signal transduction and meta-
bolic regulation are quickly degraded by the proteasome (Hershko &
Ciechanover, 1998), whereas some constituents of abundant protein
complexes (such as the ribosome and the spliceosome) are
extremely stable (Cambridge et al, 2011; Boisvert et al, 2012).
Short-lived proteins are predicted to have an increased aggregation
potential, which often places them central in protein deposition
diseases correlated with ageing and reduced proteasome activity (De
Baets et al, 2011). Estimations of the impact of protein turnover on
gene regulation revealed that protein synthesis and degradation
rates are comparable for proteins within functional protein classes
and among individual components of macromolecular protein
complexes (Kristensen et al, 2013). As such, protein stability is
undoubtedly a key component that regulates the outcome of gene
expression and shapes cellular phenotypes. Large-scale studies of
proteome dynamics in living cells were made possible by applying
stable isotope labelling, including SILAC (stable isotope labelling by
amino acids in cell culture), in combination with mass spectrome-
try. To measure protein turnover, cells are usually pulsed with
media containing stable isotopic variants of essential amino acids
and the rate of incorporation of these newly added isotopes then
enables calculating the protein half-life (Doherty et al, 2009;
Cambridge et al, 2011; Schwanhausser et al, 2011).
In several recent N-terminomics analyses using mouse and
human cell lines, we showed that the prevalence of translation start
sites not annotated in protein sequence databases was underesti-
mated as we found that 10–20% of all protein N-termini resulted
from alternative translation initiation events, point to inadequately
annotated protein start sites or to alternative splicing (Menschaert
et al, 2013; Koch et al, 2014; Van Damme et al, 2014). Scarce
evidence indicates that alternative translation initiation can produce
protein variants—proteoforms (Smith & Kelleher, 2013)—that differ
in stability when compared to their database-annotated counterparts
(Song et al, 2009). As an example, alternative translation initiation
of the opioid receptor that results in an N-terminal protein extension
rich in lysine residues and prone to ubiquitination contributes to the
high degradation rate of this proteoform (Song et al, 2009).
Triggered by such atomistic studies, we set out to study on a
more global scale if N-terminal proteoforms derived from the same
gene showed different stabilities. In contrast to other proteome stud-
ies that do not distinguish between N-terminal proteoforms, we here
combine SILAC pulse labelling (Boisvert et al, 2012) (pSILAC) with
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N-terminal COFRADIC (COmbined FRActional DIagonal
Chromatography) (Gevaert et al, 2003) to study the stability and
turnover rates of proteoforms with heterogeneous N-termini. Impor-
tant here is that we rely on known (previously identified, Van
Damme et al, 2014) N-terminal modifications to unambiguously
assign an identified peptide as a proxy for a protein’s N-terminus.
Indeed, N-termini of eukaryotic proteins typically undergo co-
translational modifications, which can be used to discriminate
N-termini pointing to translation initiation events from those point-
ing to proteolytic cleavage using mass spectrometry (Van Damme
et al, 2009). For example, methionine aminopeptidases typically
remove the initiator Met (iMet) if the side chain of the next amino
acid has a small gyration radius as found in alanine (Ala), valine
(Val), serine (Ser), threonine (Thr), cysteine (Cys), glycine (Gly) or
proline (Pro) (Frottin et al, 2006). Subsequently, the alpha-amino
group of the resulting N-terminus, with the exception of Pro, are
frequently modified by N-terminal acetylation (Nt-acetylation) catal-
ysed by N-terminal acetyltransferases (Nt-acetyltransferases or
NATs) (Arnesen et al, 2009). iMet-retaining N-termini may also be
Nt-acetylated, largely depending on the sequence specificity of the
NAT involved (Van Damme et al, 2011, 2012). Taken together, up
to 90% of all human proteins undergo either partial or complete Nt-
acetylation (Starheim et al, 2012). For several cases, Nt-acetylation
was shown to alter protein interactions, functions and structure
(Skoumpla et al, 2007; Scott et al, 2011; Shemorry et al, 2013; Dikiy
& Eliezer, 2014). Moreover, protein N-termini have other unique
properties, such as increased disorder in their secondary structure
(Holmes et al, 2014). Surprisingly, the length of N-terminal disorder
strongly correlates with the probability of protein Nt-acetylation,
with highly disordered sequences being more frequently Nt-acety-
lated. As a consequence, it was suggested that Nt-acetylation may
play a role in structural stabilisation. More specifically, Nt-acetyla-
tion of alpha-synuclein was shown to stabilise the helicity of its
N-terminus (Dikiy & Eliezer, 2014) and loss of Nt-acetylation seems
to inhibit aggregation of prion proteins (Holmes et al, 2014). More-
over, Nt-acetylation may have important roles in protein stability.
Although it was long believed that Nt-acetylation may prevent
protein degradation by the ubiquitin system (Hershko et al, 1984),
other studies indicated that Nt-acetylated proteins are not signifi-
cantly more stable or shielded from proteolytic degradation (Brown,
1979). The N-end rule further explores the relationship between the
in vivo protein half-life and the identity of a protein’s N-terminal
amino acid(s). In summary, the N-end rule links the removal of
protein substrates covering the whole spectrum of N-terminal identi-
ties, except of Pro- and Gly-starting N-termini. Degradation signals
encoded by N-terminal residues, referred to as N-degrons, may be
recognised by specialised E3 ubiquitin ligases and the N-end rule
consists of two major branches, being the Arg/N-end rule and the
Ac/N-end rule pathways. The Arg/N-end rule targets unmodified
iMet-starting N-termini followed by a hydrophobic amino acid (Kim
et al, 2014) and neo-N-termini generated upon proteolytic cleavage
(Piatkov et al, 2012; Kim et al, 2014). The acetylation-dependent
branch of the N-end rule (Ac/N-end rule) mediates a targeted degra-
dation of proteins with Nt-acetylated Met, Arg, Val, Ser, Thr and
Cys residues (Hwang et al, 2010). Interestingly, Nt-acetylation of
two N-terminal proteoforms raised by alternative initiation of SNC1
in Arabidopsis thaliana had an opposing effect on proteoform stabil-
ity dependent on the NAT involved (Xu et al, 2015). The longest
form was destabilised by NatA, whereas NatB-mediated Nt-acetyla-
tion increased the stability of the truncated proteoform. On the other
hand, recent studies of human Ogden syndrome caused by a NatA
loss-of-function mutation indicated that Nt-acetylation was involved
in the increased stability of the NatA substrate THOC7 (Myklebust
et al, 2015). Next to the N-end rule, additional mechanisms have
been shown to repress undesirable protein degradation. For exam-
ple, N-degrons may be shielded by proper folding of the mature
protein or by integration into macromolecular complexes (Eisele &
Wolf, 2008; Shemorry et al, 2013; Park et al, 2015).
To summarise, alternative translation initiation and co-
translational modifications seem to contribute substantially to the
diversity of protein N-termini and are implicated in the regulation
of protein turnover. Evidently, a comprehensive characterisation
of N-terminal proteoforms linked to their stability is of great
importance.
Results
We combined N-terminal COFRADIC, a positional proteomics tech-
nology that enables the enrichment of N-terminal peptides, with
pSILAC for the identification of N-terminal proteoforms and charac-
terisation of their cellular stability in human Jurkat T-lymphocytes.
Following database searching, we retained N-termini starting at
position 1 or 2 that point to “database-annotated” translation initia-
tion sites (dbTIS). Next, we inspected N-terminal peptides starting
beyond position 2 and selected those peptides that comply with the
rules of iMet processing and Nt-acetylation (Arnesen et al, 2009;
Van Damme et al, 2011). Proteoforms linked to these N-terminal
peptides were expected to be mainly derived from the use of alterna-
tive translation initiation sites (aTIS).
Overall, we identified 2,578 N-terminal peptides (Table EV1A),
including 2,135 dbTIS and 443 aTIS. Our study demonstrates that
N-terminal proteoforms raised upon translation initiation and alter-
native iMet processing contribute substantially to the diversity of
the human proteome. Indeed, we identified 335 N-terminal proteo-
forms derived from 133 genes displaying multiple N-termini raised
from different translation initiation sites (Fig 1A). Additionally, we
observed 81 proteoforms resulting from partial iMet processing
(Fig 1A). Of note, 63% of all aTIS were identified in the absence of
their canonical counterparts.
Diversity of N-terminal proteoforms
Deviations from the canonical translation mechanism such as ribo-
some leaky scanning and re-initiation (Sonenberg & Hinnebusch,
2009; Hinnebusch, 2011) allow for selection of alternative transla-
tion initiation sites within one transcript and, together with mRNA
splicing, contribute to the N-terminal proteoform diversity observed
in our study. Leaky scanning is a mechanism by which a fraction of
ribosomes omits less favourable start codons to initiate translation
downstream (Kozak, 2002; Gawron et al, 2014). Ribosome profiling
previously demonstrated (Lee et al, 2012) that leaky scanning is
responsible for most database non-annotated TIS selection events
and that the efficiency of downstream initiation is heavily
dependent on the strength of the translation initiation context
surrounding dbTIS, a finding corroborated by our previously
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obtained N-terminomics data (Van Damme et al, 2014). To study
the contribution of (alternative) translation initiation and splicing to
N-terminal proteoform expression in more detail, we performed
ribosome profiling experiments in Jurkat cells. Additionally, the
N-terminal peptides identified in our proteomics experiment in the
Swiss-Prot database were mapped to alternative databases: human
Swiss-Prot Isoform, UniProt TrEMBL and Ensembl.
Ribosome profiling, or Ribo-Seq, enables studying in vivo protein
synthesis by deep sequencing of ribosome-associated mRNA
fragments, thereby providing a genome-wide snapshot of actively
translated mRNAs. Additionally, (alternative) translation initiation
can be studies with sub-codon to single-nucleotide resolution
through the use of antibiotics such lactimidomycin (LTM), which
exclusively inhibit initiating ribosomes (Lee et al, 2012).
Using ribosome profiling, of the 2,578 N-terminal proteoforms
identified by means of N-terminomics, we were able to confirm
translation initiation for 89% of dbTIS (1,895 of 2,135) and 29% of
aTIS (130 of 443 aTIS) in Jurkat cells (Fig 1B and C). Using a
Mann–Whitney one-sided test, we further confirmed that aTIS
detected by Ribo-Seq (130) had significantly lower translation initia-
tion signal (RLTM-CHX) at the start codon compared to dbTIS (1,895)
(P-value = 0.011). The same was observed when directly comparing
dbTIS to aTIS variants (31 pairs) detected by Ribo-Seq and originat-
ing from the same gene (Wilcoxon signed-rank test for paired
samples; P-value of 0.00068). Further, from the data mapping to
Ensembl and Swiss-Prot Isoforms databases, we found that 23% of
the aTIS proteoforms (101 out of 443) could likely be explained by a
database-annotated alternative splicing event (Fig 1D). Additionally,
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Figure 1. The origin of N-terminal proteoforms.
A 2,578 proteoforms were identified including 2,135 dbTIS and 443 aTIS. For the majority of proteins, we found a unique translation initiation site (grey). Additionally,
335 N-terminal peptides pointed to proteins with multiple N-termini created by alternative translation initiation (blue), whereas 81 N-termini were generated by
alternative iMet processing (green).
B, C Proteomics-derived translation initiation events were verified at the transcript level using Ribo-Seq data obtained in Jurkat cells and HCT116 cells (data
unpublished). Although in this study, the degree of in vivo Nt-acetylation could not be directly determined, all retained N-termini were compliant with the rules of
N-terminal processing (Van Damme et al, 2014). In the case N-termini were found to be in vivo Nt-acetylated (previous MS/MS-based evidence, Van Damme et al,
2014), this information is indicated. dbTIS and aTIS peptides were further mapped to protein N-termini annotated in Swiss-Prot Isoform, UniProt TrEMBL and
Ensembl databases and neo-N-termini (proteolytic products) of the knowledgebase TopFind 3.0. The number of matching N-termini is indicated in dark grey.
N-terminal peptides supported by at least one source of metadata pointing to translation (Nt-acetylation, Ribo-Seq, Swiss-Prot Isoforms, TrEMBL or Ensembl) were
classified as highly confident TIS (indicated in green).
D Using experimental and metadata, we assigned the most likely origin of aTIS peptides and confirmed that alternative translation initiation within the same
transcript (leaky scanning) contributes to the majority of alternative TIS identified.
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only 19 aTIS N-termini were annotated in the proteolytic knowl-
edgebase of protein N-termini, TopFIND 3.0, as potential protease
cleavage products (Fortelny et al, 2015) (Fig 1C). However, of these
seven could be disregarded due to Nt-acetylation evidence and/or
Ribo-Seq confirmed TIS selection. Overall, given the N-terminal
selection strategies applied and the metadata at hand, only very few
of the here reported N-termini can be considered as potential prote-
olytic products. The majority of remaining N-terminal proteoforms
(330) is thus likely generated upon leaky scanning or other transla-
tion initiation mechanism as previously shown by others and us
(Lee et al, 2012; Van Damme et al, 2014). Leaky scanning
frequently results in initiation at a downstream start codon in the
immediate proximity of the first AUG codon (Fig 2A) (Van Damme
et al, 2014); however, supported by Ribo-Seq data, we found exam-
ples of translation initiation by means of leaky scanning at more
distant start codons (Fig 2B). Relying on the current Ensembl
human transcriptome annotation and splice variants present in the
Swiss-Prot Isoform database, we were additionally able to confirm
the expression of N-terminal proteoforms from alternatively spliced
transcripts (Fig 2C).
Interestingly, we found 12 aTIS proteoforms being exclusively
expressed in the absence of dbTIS, judging from the lack of preced-
ing Ribo-Seq and proteomics evidence (Van Damme et al, 2014)
(Fig 2D). The two most likely scenarios leading to the creation of
N-terminal proteoforms starting at two consecutive Met residues
(e.g. at positions 1 and 2) are leaky scanning or alternative iMet
processing. Our proteomics data provide evidence of consecutive
Met-starting N-termini for 11 genes and matching Ribo-Seq data
indicate that translation initiation may occur at both Met residues
(Fig 2E and F).
UBA1 gene: Met at position 1 and 41 are TIS,
alternative translation initiation at exon 2 and 3
MAPRE2 gene: Met at position 1 and 44 are TIS,
alternative splicing of exon 1 and 2 C
B
G3BP1 gene: Met at position 1 and 3  are TIS,
alternative translation initiation in the same exonA
Gene
transcript
Jurkat LTM
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Figure 2. Examples of translation initiation events confirmed by Ribo-Seq in Jurkat cells.
A, B Alternative translation initiation due to leaky scanning.
C Alternative splicing.
D The preferential expression of an N-terminally truncated proteoform.
E, F Evidence for alternative translation initiation occurring at two consecutive AUG codons.
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Protein turnover measurement
To measure turnover times of N-terminal proteoforms, we used
human Jurkat T-lymphocytes that were pre-labelled with either light
(Arg0) or medium (Arg6) isotopes of arginine and harvested 0.5, 1.5,
4, 8, 12, 24 or 48 h after a label swap to light or heavy arginine
(Arg10) containing medium (see Fig 3A). Note that arginine was
used as the SILAC label given that by nature of the N-terminal
COFRADIC procedure, all N-terminal peptides end on arginine. After
mixing equal amounts of light and medium/heavy labelled proteome
samples taken at the seven different time points, N-terminal
COFRADIC analyses were performed.
From the total of 2,578 N-terminal peptides identified
(Table EV1A), we retained 1,972 peptides that were identified in at
least three of the time points analysed (Table EV1B). Their SILAC
ratio values were then used to calculate protein stabilities by moni-
toring protein degradation and synthesis based on changes in M/L
and H/L isotope ratios, with the crossing point between the degra-
dation and synthesis profiles enabling a direct read-out of the 50%
protein turnover (Fig 3B) (Boisvert et al, 2012). Using a simple
exponential model, we calculated turnover times for 1,928 (98%) of
the 1,972 proteoforms with minimal R2 coefficients ≥ 0.8. To evalu-
ate the relationship between the number of observations and the
predictive power of our model, we re-calculated turnover times of
Arg 0
(Light)
Arg6
(Medium)
Arg10
(Heavy)
Arg0
(Light)
PRE-LABELING
LABEL SWAP
COLLECTING,
MIXING 1:1
0.5
1.5
4
8
12
24
48
hours
N-TERMINAL COFRADIC
(enrichment of N-terminal peptides)
MS/MS ANALYSIS
0
10
20
30
40
50
0 10 20 30 40 50
50% turnover time [h]
co
u
n
t
100                        
50                        
0                        
R
.I.
tim
e
tim
e
Arg 0
(Light)
Arg 0
(Light)
Arg 6
(Medium)
Arg 10
(Heavy)
M/L 
DEGRADATION
H/L
SYNTHESIS
50% TURNOVER
time
0.5
M/L
H/L
crossing point
time
H/L
time
M/L
B
median 
turnover = 21.6 h 
C cell 
doubling = 24 h 
A
Figure 3. Experimental set-up using pSILAC and N-terminal COFRADIC to assess N-terminal proteoform stability.
A Jurkat cells were pre-labelled with light or medium L-Arg isotopes. A label swap was performed of cells growing in medium Arg, whereas light cells were cultured in
the same medium. Cells were harvested at different time points and equal proteome amounts were mixed, followed by N-terminal COFRADIC and LC-MS/MS analysis.
B Ratios between three dynamic forms of N-terminal peptides reflect protein synthesis and degradation rates, allowing the calculation of 50% turnover times.
C The distribution of turnover times (N = 1,894) calculated was not unimodal, with a sizable number of quickly turned over proteins and the median protein turnover
rate being 21.6 h. The doubling time of Jurkat cells (24 h) is indicated in red.
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selected proteoforms based on a subset of available observations,
showing that turnover times can be precisely reproduced using as
few as three randomly selected data points (Fig EV1). Our model
very well described the variation in experimental data (as supported
by a high median R2 value of 0.98; see Fig EV2), overall
demonstrating that protein degradation in Jurkat cells follows
mono-exponential kinetics. Only a minority of degradation and
synthesis curves (2%) showed monotonic changes in time not
following an exponential trend (R2 < 0.8). In 13 such cases, turn-
over times were determined using a linear interpolation of the
crossing point, but otherwise such proteoforms were excluded from
further analysis. In total, we could assign 50% turnover times to
1,941 N-terminal proteoforms (Table EV1B).
To account for cell growth, our exponential model of protein
degradation incorporated the doubling time measured for Jurkat
cells (24 h, see Fig EV3). This allowed for the determination of two
additional parameters, namely protein degradation rate constants
(kdeg) and protein half-life values [h]. Since 50% turnover values
can be measured more directly and reflect both protein synthesis
and degradation, we selected 50% turnover time as the desired
parameter to perform our subsequent analyses.
Protein function and turnover: correlation with previous reports
Overall, protein turnover times in Jurkat cells varied from < 1, to
more than 48 h with a median turnover time of 21.6 h (Fig 3C).
Protein degradation constants determined for Jurkat cells (control
sample) (Fierro-Monti et al, 2013), protein turnover times measured
in HeLa cells (whole cell lysates) (Boisvert et al, 2012) and protein
half-lives derived from NIH3T3 mouse fibroblasts (Schwanhausser
et al, 2011) were retrieved and compared to their corresponding
values of canonical proteoforms quantified in our study. We
detected a moderate correlation between our data and previous
reports, with Spearman rank correlation coefficients reaching 0.49
for HeLa data (Boisvert et al, 2012), 0.48 for NIH3T3 data
(Schwanhausser et al, 2011) and 0.44 for Jurkat data (Fierro-Monti
et al, 2013). Moreover, a median protein half-life of 50.5 h
measured in our study was in good agreement with previously
reported values in mouse NIH3T3 cells (47.8 h) (Schwanhausser
et al, 2011) and human Jurkat cells (55.8 h) (Fierro-Monti et al,
2013). Further, we observed a highly similar median turnover time
(21.6 h) and turnover distribution to estimates obtained in HeLa
cells (20 h) (Boisvert et al, 2012).
Based on gene ontology (GO) biological process term enrichment
of our data using the Gorilla software (Eden et al, 2009) and consid-
ering one proteoform per gene, we found that proteins with
common functional annotations displayed comparable cellular
stabilities. To reduce the complexity and redundancy of enriched
categories, we applied REViGIO (Supek et al, 2011) and visualised
selected GO terms with false discovery rate (FDR) q-values lower
than 0.05. Unstable proteins were more often involved in mitosis,
chromosome segregation, cell cycle and apoptosis, next to regula-
tion of RNA transcription and protein ubiquitination (Fig 4A). On
the other hand, RNA splicing, protein translation, folding and trans-
port as well as various metabolic processes of carbohydrates,
nucleotides, aldehydes, ketones, glutathione, nitrogen and phospho-
rus were conducted by more stable proteins (Fig 4B). Along the
same line, category enrichment analysis of KEGG pathway terms
clearly pointed to increased stability of spliceosome and ribosome
components next to RNA degradation, aminoacyl-tRNA biosynthe-
sis, glycolysis and gluconeogenesis, and pentose phosphate
pathways (all with FDR values below 9.0E-04) (Schwanhausser
et al, 2011; Boisvert et al, 2012). Pfam data did not point to a signif-
icant influence of protein domain composition on protein turnover.
Overall, the results of our annotation enrichment analysis agree
very well with previous studies in mouse (Schwanhausser et al,
2011) and human (Boisvert et al, 2012; Fierro-Monti et al, 2013),
and thus, protein turnover rates seem to be conserved between dif-
ferent cell lines and organisms, especially at the level of protein
groups and biological processes.
Stability, abundance and structural disorder of
alternative proteoforms
To facilitate the interpretation of the relationship between alterna-
tive translation and protein turnover, whenever an iMet-retaining
and iMet-processed proteoform were identified, we only selected the
expected mature N-terminus per proteoform, according to the rules
of iMet processing (Frottin et al, 2006). In total, we assigned protein
turnover rates for 323 aTIS and 1,571 dbTIS N-terminal proteoforms
(Fig 5A).
The majority of the identified aTIS resulted in relatively short
N-terminal protein truncations (protein length reduced by less than
13%). The distribution of aTIS corresponding iMet positions centred
within the first 200 amino acids with a median position of 52
(Fig 5B), an observation in line with the fact that leaky ribosome
scanning is likely to be responsible for the majority of downstream
translation events observed (see above and Lee et al, 2012; Van
Damme et al, 2014).
Interestingly, N-terminal proteoforms derived from aTIS usage
frequently displayed distinct stabilities (Fig 5C). We were able to
quantify turnover rates of 100 dbTIS/ aTIS pairs and observed that
some aTIS displayed altered stabilities as compared to their dbTIS
counterparts. More specifically, we detected numerous examples of
aTIS proteoforms with increased as well as decreased stability
(Fig 6A and B). This effect appeared not to correlate with the
distance between aTIS and dbTIS positions (Fig 6C). Since the dif-
ferences in stabilities between aTIS and dbTIS expressed forms of
the same gene were not uniform, no statistical difference was
detected between their turnover times (Fig 6C, Table 1). However,
when we compared the entire populations of aTIS to dbTIS, alterna-
tive proteoforms were on average found to be significantly more
stable (P-value = 1.52e-08) (Fig 5C, Table 1).
We further determined whether aTIS indicative N-termini share
features that are distinct from dbTIS. Given that translation is a one-
directional process and downstream initiation due to leaky scanning
only occurs with a limited probability, in a normal cellular context
one might expect that many aTIS variants are less efficiently
produced than dbTIS variants, leading to lower abundance of the
former (Michel et al, 2014; Van Damme et al, 2014). To investigate
this, we used spectral counts as well as NSAF scores (Paoletti et al,
2006) as quantitative proteoform measures. Using a Mann–Whitney
one-sided test to compare the aTIS (323) and dbTIS (1,571) groups,
we confirmed that, on average, aTIS variants are less abundant with
high significance values when using both spectral counts
(P-value = 4.31e-09) and NSAF scores (P-value = 1.15e-07). The
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same was observed when directly comparing dbTIS to aTIS variants
originating from the same gene using a Wilcoxon signed-rank test
for paired samples (P-values of 3.44e-09 and 6.45e-09, respectively,
for spectral counts and NSAF, see Table 1). Finally, we observed
a slight positive correlation between turnover time and protein
abundance (Spearman rank correlation of 0.285). Further analysis
indicated reduced levels of the top 10% of unstable proteins and
higher levels of the 10% most stable proteins in relation to the mean
protein abundance in our data set (Benjamini–Hochberg FDR of
2.29e-11 and 7.44e-05, respectively).
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Figure 4. GO term enrichment analysis for unstable (A) and stable (B) proteins.
A, B Horizontal bar chart representations are given for significantly enriched GO terms in the human proteome (FDR q-value ≤ 0.05).
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Intrinsic disorder in protein structures is an important factor that
determines protein degradation rates (reviewed in Babu et al,
2011). The extent of structural flexibility can be assessed, among
others, by studying the amino acid composition of proteins
(Dosztanyi et al, 2005b). For every proteoform sequence, the
percentage of intrinsically disordered regions was predicted using
the RAPID server (Yan et al, 2013). The average disorder of aTIS
proteoforms was found to be higher than that of dbTIS proteoforms
(Mann–Whitney one-sided test, P = 0.00157). These observations
were confirmed in paired samples of aTIS and dbTIS products of the
same gene (Wilcoxon signed-rank test, P = 0.01216, see Fig 6D). In
conclusion, aTIS proteoforms were characterised by lower expres-
sion levels and higher structural flexibility than dbTIS proteoforms.
Moreover, the aTIS population displayed an overall higher stability
compared to dbTIS. Additionally, a low negative correlation was
observed between protein turnover and the percentage of disordered
sequence (Spearman rank correlation of 0.209), suggesting that
unstable proteins tend to have more disordered regions, as reported
in previous studies (Doherty et al, 2009; Kristensen et al, 2013).
In line with this, the 10% most stable proteins had significantly
lower disorder content, contrary to the 10% least stable proteins
with highly disordered structures (Benjamini–Hochberg FDR of
3.27e-11).
Protein turnover and N-terminal amino acid composition
We next investigated whether the identified N-termini hold intrinsic
information on the so-called N-degrons (Kim et al, 2014), and what
the role is of iMet cleavage in this process.
To correlate the N-end rule with our pSILAC data set, we exam-
ined the relation between the turnover rate and the identity of the
two utmost N-terminal residues. A Bartlett test indicated insufficient
homogeneity of variance between the studied groups, leading to the
selection of non-parametrical tests for further analysis. First, we
performed a pairwise comparison of protein stability across
N-termini grouped according to their N-terminal amino acid iden-
tity. A Kruskal–Wallis rank sum test indicated a significant impact
of N-terminal residues on protein turnover, whereas a subsequent
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Figure 5. Characterisation of identified N-terminal proteoforms.
A We assigned the turnover time of 1,941 proteoforms, including 1,894 proteoforms derived from 1,571 dbTIS and 323 aTIS next to 47 N-termini generated by
alternative iMet processing. dbTIS- and aTIS-derived proteoforms are indicated in shades of blue and shades of red, respectively. Stability of 100 N-terminal
proteoform pairs derived from the same gene (dark red).
B Distribution of iMet positions giving rise to 323 N-terminal proteoforms with assigned turnover times (to avoid redundancy a single iMet-processed proteoform was
considered).
C Distribution of turnover values shows differences in the overall stability of dbTIS versus aTIS proteoforms.
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multiple comparison test allowed to indicate the most deviating
pairs (with P < 0.05). Met-Asn and Met-Asp were among the least
stable N-termini which deviated significantly from stable N-termini
such as Met-Thr-, Met-Val-, Met-Ala- and Pro-starting N-termini
(Fig 7A).
To further dissect our data, we compared the stability of
N-termini undergoing iMet processing, leading to N-terminal Ser,
Ala, Thr, Cys, Val, Gly and Pro. Interestingly, a general lower stabil-
ity was observed for proteoforms with their iMet residue removed
compared to proteoforms that retained the iMet. A significant
impact of iMet processing on turnover rates was confirmed using a
Kruskal–Wallis rank sum test (P < 2.2e-16). To decouple the effect
of Nt-acetylation from iMet processing, we compared completely or
partially Nt-acetylated (Ser, Ala, Thr, Cys, Val, Gly) to in vivo free
(Pro) N-termini, and for both groups, we observed a lower stability
of proteoforms with their iMet removed (see Fig 7B). Considering
individual amino acids, only Thr and Val deviated significantly from
their corresponding iMet-retaining N-termini (see Fig 7B and C).
However, a less strict analysis with pairwise Wilcoxon rank sum
test (without correction for multiple testing) pointed to significant
deviation between iMet-processed and iMet-retaining Ala-, Ser- and
Gly-starting N-termini. To conclude, turnover rates of N-termini
with different susceptibility for Nt-acetylation (Van Damme et al,
2011) were generally affected by iMet processing.
These findings suggest that irrespective of (the degree of) Nt-
acetylation, iMet processing, rather than Nt-acetylation, seems to be
a main contributing factor to N-terminal proteoform stability. In
particular and in line with previous findings (Brown, 1979), no
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Figure 6. N-terminal proteoforms may display different stabilities.
A Degradation profiles of AIMP2, MARE2 and AN32E dbTIS and aTIS proteoforms as representative examples of N-terminal proteoforms that differ in stability.
B MS spectra of the N-termini of two proteoforms originating from the aminoacyl-tRNA synthase complex-interacting multifunctional protein 2 (AIMP2): a dbTIS
indicative N-terminus with processed iMet and starting at the second amino acid Pro, an aTIS indicative peptide starting at position 3 and retaining its iMet. As
evident from the MS spectra shown, these N-terminal proteoforms displayed largely different turnover rates.
C Differences in turnover times were calculated for 100 dbTIS and aTIS proteoform pairs and presented in ascending order. The extent of N-terminal truncation in each
pair was colour-coded to visualise the absence of correlation between the number of lacking amino acids and the direction of turnover shift.
D An increase in disorder content between aTIS and dbTIS proteoforms can be observed for a multitude of dbTIS/aTIS pairs.
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correlation was found with the Nt-acetylation susceptibility of
protein N-termini (Fig 7B). Secondly, the presence of a hydrophobic
residue at the second position has no apparent influence on average
turnover rates as proteins starting with N-termini such as Met-Leu,
Met-Phe, Met-Tyr and Met-Ile have stabilities close to the median
stability of all protein N-termini (Fig 7A). A more detailed analysis
of grand average of hydropathy (GRAVY) of 2 and 10 most
N-terminal residues revealed no correlation with protein turnover
times (Spearman correlation coefficients of 0.013 and 0.0085,
respectively).
Ubiquitination and protein turnover
Post-translational modifications, such as ubiquitination, may affect
protein stability and are thus worthwhile to consider in the context
of N-terminal proteoforms. Ubiquitination has a known, direct
impact on protein degradation and was previously studied at the
proteome-wide level using Jurkat cells as a model system (Stes
et al, 2014). Our group reported on a compilation of more than
7,500 in vivo ubiquitinated peptides in more than 3,300 different
proteins (Stes et al, 2014). Using this data set, we investigated
whether annotated N-terminal proteoforms holding possible (previ-
ously identified) ubiquitination sites displayed different stabilities
than proteoforms not found to be ubiquitinated. We compared the
stability of 348 dbTIS containing at least one detected ubiquitina-
tion site to 388 N-termini with one or more lysine residues but no
experimental evidence of ubiquitination in Jurkat cells. A one-sided
Mann–Whitney U-test revealed a significant higher median stability
of ubiquitinated proteoforms compared to non-ubiquitinated
proteoforms (P = 0.0005; see Fig EV4), although in each case a
very broad range of protein stabilities could be observed. To
provide more insight, we decided to investigate particular cases of
ubiquitinated N-termini. The existence of additional ubiquitination
sites may contribute to the difference in turnover observed between
longer and shorter proteoforms, as reported in the case of the mu
opioid receptor (MOP) (Song et al, 2009). Interestingly, in our data
set, we found 31 dbTIS proteoforms holding unique ubiquitination
sites not present in a shorter proteoform (aTIS). Eleven such prote-
oforms displayed reduced stability (turnover time decreased by at
least 2 h) compared to their aTIS counterparts (Table EV2). For
these proteoforms, ubiquitination potentially contributes to the
observed differences in stability. We also found 14 proteoform
pairs where ubiquitination of the longer variant possible contrib-
uted to an increased stability and five cases were irrelevant
differences in stability between proteoform pairs were observed
(< 2 h).
Protein turnover in macromolecular complexes
Following up on a recent report on the precise regulation of protein
synthesis rates being proportional to the stoichiometry of macro-
molecular protein complexes (Li et al, 2014), we here investigated
whether protein synthesis and degradation are coordinated for
members of known macromolecular protein complexes
(Table EV1B). According to the strategy reported by Kristensen et al
(2013), we retrieved the human core protein complexes from the
CORUM database (Ruepp et al, 2010). Next, we assigned turnover
times to members of complexes using only the dbTIS proteoforms
Table 1. Differences in turnover, disorder and abundance values between aTIS and dbTIS.
Variable Data set Test P-value Conclusion
Turnover time Complete data set Mann–Whitney test 1.52e-08 aTIS>dbTIS
dbTIS/aTIS pairs Wilcoxon signed-rank test 0.5021 No difference
Disorder Complete data set Mann–Whitney test 0.00157 aTIS>dbTIS
dbTIS/aTIS pairs Wilcoxon signed-rank test 0.01216 aTIS>dbTIS
Spectral counts Complete data set Mann–Whitney test 4.31e-09 aTIS<dbTIS
dbTIS/aTIS pairs Wilcoxon signed-rank test 3.44e-09 aTIS<dbTIS
NSAF Complete data set Mann–Whitney test 1.15e-07 aTIS<dbTIS
dbTIS/aTIS pairs Wilcoxon signed-rank test 6.45e-09 aTIS<dbTIS
For the complete data set of aTIS and dbTIS with reliable turnover measurements and considering a single iMet proteoform (N = 1,894; 323 aTIS and 1,571 dbTIS),
a comparison of turnover, disorder and abundance values was performed using Mann–Whitney one-sided test for independent samples. Differences in paired
dbTIS-aTIS data were measured using a Wilcoxon signed-rank one-sided test for paired samples. All analyses were performed at P ≤ 0.05 significance level.
▸Figure 7. Relationship between N-terminal amino residue(s) identity and 50% turnover rates.A All protein N-termini were grouped according to the identity of their N-terminal residues and sorted in ascending order of stability.
B Methionine processing typically affects N-termini displaying amino acids with small gyration radii (S, A, T, C, V, G or P residues at the second position). Although the
majority of these N-termini undergo methionine cleavage, some (partially) retain their first amino acid. Subsequently, iMet-processed N-termini may be
Nt-acetylated by NatA in the following order of efficiency (S, A, T, C, V and G) with the exception of P which always remains unmodified (Van Damme et al, 2011). The
stability of iMet-processed N-termini is very similar for S-, A-, T-, C- and G- and P-starting N-termini, but their iMet-retaining counterparts have overall higher
stability, and this especially for MT and MV N-termini. In contrast to methionine processing, Nt-acetylation susceptibility does not appear to have an effect on the
stability of proteoforms. *The extent of in vivo Nt-acetylation was described by Van Damme et al (2011).
C Differences in turnover times where calculated for N-termini starting with S, A, T, C and G and P and their iMet-retaining counterparts (47 proteoform pairs with
valid turnover measurements). Decreased stability of processed N-termini could be observed, especially for T- and V-starting N-termini.
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identified in our study. We calculated the absolute difference in
stability between every protein and all other members of a given
complex. Significant outliers with statistically larger differences to
other proteins in a complex were identified using the Mann–
Whitney U-test (a = 0.05, one-sided). In this way, we estimated the
dispersion of turnover rates for 189 proteins within 173 macro-
molecular complexes with three or more members identified, and
came to the conclusion that a majority of turnover rates correlate
well within a complex (127 or 73% of the complexes). Inconsisten-
cies were observed in 46 complexes of which 74% involved a single
outlier. In 28 complexes, we detected a single unstable component,
hinting to a rate-limiting factor for complex formation.
Next, we investigated whether protein–protein interactions could
be affected by the expression of alternative N-terminal proteoforms.
Here, a comparative analysis of GO terms related to protein function
in aTIS- versus dbTIS-derived proteoforms revealed that alternative
proteoforms were clearly enriched in protein forming homomulti-
mers (FDR q-value of 0.0096) hinting to the likely impact of
alternative proteoform incorporation on the overall stability of
protein complexes.
Verification of protein turnover times
Cycloheximide (CHX) pulse-chase experiments were performed to
confirm the stability of selected proteoforms. Half-lives of six
selected endogenous proteins (Fig 8A) were assayed by Western
blotting using lysates of Jurkat cells treated with CHX for 0–48 h.
Protein levels of short-lived securin, lamin B, b-catenin and GCIP-
interacting protein p29 levels were monitored by Western blotting
and compared to those of stable proteins such as actin and GAPDH.
Protein half-lives deduced from Western blot analyses corresponded
well to those calculated from pSILAC data. Overexpression of
selected V5-tagged proteoforms in the human colorectal HCT116
carcinoma cell line allowed us to validate differential turnover of
identified dbTIS and aTIS products from two different genes:
MARE2 and AN32E (Fig 8B and C). Data from the latter experiments
further suggest that common trends can be observed in the regula-
tion of proteoform stability across different human cell lines, despite
discrepancies in the exact values calculated using CHX-chase and
pSILAC.
Discussion
The selection of translation initiation sites attributes to the complex-
ity of proteomes as N-terminally truncated and extended
proteoforms may be differentially regulated, localised (Leissring
et al, 2004; Kobayashi et al, 2009), display altered stabilities (Song
et al, 2009) and functionalities (Calligaris et al, 1995; Thomas et al,
2008; Khanna-Gupta et al, 2012) especially in the case of some large
N-terminal truncations. Proteoforms arisen from alternative transla-
tion initiation are generally well conserved among eukaryotic
orthologous protein species (Van Damme et al, 2014). Selection
between alternative translation start sites is regulated under condi-
tions of cellular stress (Gawron et al, 2014) and may change the
repertoire of N-terminal proteoforms expressed in a developmental
and tissue-specific manner (Calligaris et al, 1995; Thomas et al,
2008).
pSILAC was already used in several proteome studies to
determine the dynamic properties of thousands of proteins in a
single experiment. Most studies made use of non-synchronised,
proliferating cell lines (Selbach et al, 2008; Doherty et al, 2009;
Schwanhausser et al, 2011; Boisvert et al, 2012), while others
employed growth arrest (Cambridge et al, 2011) or studied protein
synthesis and degradation rates in dynamically changing systems
[e.g. during differentiation (Kristensen et al, 2013) or following
drug-mediated inhibition of Hsp90 (Fierro-Monti et al, 2013)]. We
decided to employ a pSILAC approach similar to the one described
by Boisvert et al (2012) which enabled the measurement of protein
half-lives (t1/2) as well as protein turnover, reflecting the overall
protein synthesis and degradation rates (Boisvert et al, 2012). To
better reflect our experimental results, we simplified the mathemati-
cal model proposed by Boisvert et al (2012). In their set-up, levels
of medium Arg were retained at 20% instead of asymptotically
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Figure 8. Comparison of protein turnover measured by pSILAC and CHX-
chase.
A Jurkat cells were treated with 100 lg/ml CHX for 0, 0.5, 1.5, 4, 8, 12 or
24 h. Protein degradation was monitored by Western blotting, and
stabilities of several short-lived endogenous proteins were confirmed
using antibodies (including lamin B, securin, b-catenin, GCIP-interacting
protein p29) and compared to stable proteins (such as GAPDH and actin).
Proteoform-specific bands were used to calculate protein half-lives
which were in a good agreement with turnover times obtained from
pSILAC
B, C Validation of the differential turnover time of the dbTIS- and aTIS-
derived proteoforms of MARE2 and AN32E. Selective C-terminal V5-
tagged proteoforms were overexpressed in HCT116 cells for 24 h, and
CHX pulse-chase experiments were performed as described for Jurkat
cells. Degradation of overexpressed proteoforms was monitored by an
anti-V5 antibody and compared to the turnover of stable proteins such
as actin and tubulin.
Source data are available online for this figure.
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approaching zero as degradation of proteins proceeds, an observa-
tion which they attributed to amino acid recycling. In Jurkat cells,
we observed a complete isotope replacement, similar to another
recent pSILAC study conducted in the same cell line (Fierro-Monti
et al, 2013).
Here, we performed a first global, N-terminal proteoform-specific
analysis of protein stability and identified numerous N-terminally
truncated proteoforms with distinct turnover rates compared to their
full-length counterparts. Among the compared dbTIS/ aTIS pairs,
the stability of alternative proteoforms was not correlated to the
length of truncation. The regulation of protein turnover rather
seemed proteoform-specific, pointing to many different factors
involved in the synthesis and degradation of specific proteins. One
such contributing factor may be post-translational modifications, as
we found 11 proteoform pairs where ubiquitination of the longer
variant possible contributed to reduced proteoform stability.
To validate the difference in half-lives of selected proteoform
pairs, we turned to the use of a more classic method for measuring
protein turnover, being CHX pulse-chase experiments followed by
Western blot analysis. We confirmed turnover rates of several
endogenously expressed short- and long-lived proteins. Due to the
limitation in molecular weight resolution and sensitivity, we subse-
quently turned to overexpression studies for the validation of
differential N-terminal proteoform stabilities from two human
genes. Nonetheless, since upon incubation of the cells with protein
synthesis inhibitors, protein degradation may be altered (Hanna
et al, 2003; Dai et al, 2013), and cell toxicity can only be controlled
for a relatively short period; CHX treatment may preclude a correct
delineation/validation of long protein half-lives.
We further evaluated the origin of N-terminal proteoforms identi-
fied in our study using ribosome profiling and extensive mining of
public databases (Table EV1C) and found that 74% of the aTIS were
generated by alternative translation initiation, whereas 23% likely
pointed to splicing events. Truncated proteoforms displayed a lower
translation initiation signal at the start codon, in line with their
reduced proteome abundance estimated by spectral counting. These
finding are consistent with a lower frequency of downstream
translation initiation assumed from the leaky scanning model of
translation initiation and corroborated by previous reports (Lee
et al, 2012). Next to their lower abundance, the limited overlap
between aTIS identified by means of proteomics and Ribo-Seq might
be additionally attributed to the TIS calling approach used, since
typically a higher interference is observed at internal TIS typically
flanked by signal at both 50 and 30 end. Moreover, some aTIS may
actually be the sole or preferential TIS site selected due to alterna-
tive splicing and, in some cases, alternative translation initiation. In
this context, previous studies demonstrated that their corresponding
dbTIS sites are typically embedded in less optimal Kozak consensus
sequences (Van Damme et al, 2014). Indeed, we found 12 aTIS
proteoforms exclusively expressed in the absence of dbTIS at both
the translatome and the proteome levels. In some cases, a truncated
proteoform may also display superior stability over the canonical
proteoform. Viewing their general lower abundance, stable aTIS
proteoforms are more likely to be detected. The latter could explain
why the aTIS population was slightly enriched for long-lived
proteins.
As reported previously (Cambridge et al, 2011; Kristensen et al,
2013), turnover rates were similar for proteins belonging to similar
functional groups or macromolecular complexes. This is supported
by the notion that some proteins get stabilised upon complexation
with other proteins, lipids, sugars or nucleotides (Cambridge et al,
2011). In line, other studies suggested that protein subunits turn
over quickly where the complex is assembled, but are stabilised in
cellular compartments where the complex is functional (Boisvert
et al, 2012). Some of the identified protein truncations are predicted
to be benign for a protein’s function or binding but have large
consequences for protein stability. For example, a single amino acid
truncation of AIMP2 increases protein stability (see Fig 6A and B)
but was not predicted to alter its sequence disorder content, localisa-
tion [TargetP (Emanuelsson et al, 2000), WoLF PSORT (Horton
et al, 2007)] or any of its known interacting domains. Considering
such cases, a differential regulation of N-terminal proteoform stabil-
ity may potentially result in elimination or introduction of unstable
components into a complex. It is also important to consider that the
relative expression levels of proteoforms are responsive to cellular
conditions (Touriol et al, 2003; Thomas et al, 2008; Leprivier et al,
2014). In this context, depletion of one proteoform may increase the
impact of another proteoform’s turnover on protein complex forma-
tion. As we observed that aTIS proteoforms were enriched in
proteins forming homomultimers, generation of alternative proteo-
forms may be important in the context of homomultimerisation.
Interestingly, in the case of the transcription factor GATA-1, proteo-
forms generated by alternative translation initiation were already
shown to produce dimers (Calligaris et al, 1995) with altered activi-
ties dependent on the relative ratios of the two proteoforms in the
complex.
The extent of intrinsic disorder in protein structures was corre-
lated with turnover times, indicating that a change in structural
flexibility of protein N-termini from truncated proteoforms might
have an impact on the proteoforms’ cellular stabilities. In line with
the observation that proteins displaying iMet cleavage are overrep-
resented in vivo, the general belief is that retained iMet reduces the
stability of proteins (Meinnel et al, 2005; Frottin et al, 2006).
Unexpectedly, our stability data showed a reduced stability of iMet-
processed proteoforms in numerous cases. However, it is important
to discriminate between the effect of iMet removal on protein abun-
dance and the effect on protein turnover time, as these two terms
should not be used interchangeably. Relying on previous quantita-
tive data on protein Nt-acetylation (Van Damme et al, 2014),
another common co-translational modification, Nt-acetylation
seemed to have no overall impact on turnover rates. Of note
however, due to the experimental methodology applied, we cannot
distinguish Nt-acetylated from Nt-free proteoform counterparts. In
fact, the role of Nt-acetylation in protein stability is debated (Brown,
1979; Hershko et al, 1984) and is likely protein context and NAT
dependent (Myklebust et al, 2015; Xu et al, 2015). It was postulated
that Nt-acetylation may stabilise otherwise flexible structures of N-
termini and reduce their propensity for aggregation (Holmes et al,
2014). At the same time, acetylated protein N-termini are substrates
of the N-end rule pathway (Hwang et al, 2010) which may
constitute a clearance mechanism for N-terminally misfolded or
non-complexed proteins (Eisele & Wolf, 2008; Heck et al, 2010;
Shemorry et al, 2013; Park et al, 2015). Moreover, it is difficult to
directly compare our results to the destabilising properties of the
corresponding N-terminal amino acids originally described by
Varshavsky and colleagues, especially considering differences in the
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studied organisms and the techniques used for protein turnover
determination (pSILAC vs. CHX-chase). We believe that the
property of iMet retention to increase the stability of N-terminal
proteoforms described in our study may exist as an additional mech-
anism next to the N-end rule pathways to ensure the fine-tuning of
protein stability in eukaryotic cells.
Recent large-scale studies on protein stability report a limited
correlation to other high-throughput data and especially differences
in the methodologies applied appear to account for the observed
discrepancies (Yen et al, 2008; Doherty et al, 2009; Cambridge et al,
2011; Eden et al, 2011; Boisvert et al, 2012). In this context, pSILAC
approaches share general advantages, as they target endogenous
proteins expressed at physiological levels in untreated cells. We
therefore sought to cross-examine our present turnover data with
previous studies performed using pSILAC in human (HeLa and
Jurkat cells, Boisvert et al, 2012; Fierro-Monti et al, 2013) and
mouse (NIH3T3 cells, Schwanhausser et al, 2011). We observed a
positive correlation of our data with these other protein stability
studies, with Spearman’s correlation coefficients of 0.48, 0.44 and
0.49 (Schwanhausser et al, 2011; Boisvert et al, 2012 and Fierro-
Monti et al, 2013), respectively. Moreover, comparison of gene
ontology enrichment analyses indicated that protein turnover rates
seem to be conserved between different cell lines and organisms.
Despite similar experimental procedures, there was still a lot of
unexplained variation between the data sets, which may be attrib-
uted to differential regulation of protein stability in different cell
lines or differential growth conditions in the case of the Jurkat cell
line, while data processing and interpretation are other factors to
consider. Importantly, we clearly demonstrate the contribution of
proteoform-specific turnover rates and that differences in stability
between N-terminal protein variants may in principle only be
resolved by focusing on their unique peptides, whereas shared
peptides are a potential source of error in turnover measurements.
Protein turnover measurements were recently extended to
protein isoforms and (modified) protein pools (Ahmad et al, 2012;
Boisvert et al, 2012). The Lamond group provided evidence for dif-
ferential stabilities and localisation of proteoforms. Their shotgun
approach, however well suited to study splice variants, had limited
application for N-terminal proteoforms. Our pSILAC/N-terminal
COFRADIC approach can be further extended to study changes in
stability and proteoform expression levels during dynamic processes
or in different tissues (Fierro-Monti et al, 2013; Kristensen et al,
2013). Since targeting to diverse micro-environments allows fine-
tuning of local protein concentrations, adding a spatial context to
protein turnover may increase our understanding of the functional
diversity of proteomes in future studies.
Materials and Methods
Cell culture
For N-terminal COFRADIC analyses, human Jurkat T-lymphocytes
(clone E6-1 ATCC TIB-152, ATCC) were subjected to SILAC labelling
(Ong et al, 2002). Cells were cultured in a 5% CO2 gas-equilibrated,
humidified incubator in Roswell Park Memorial Institute (RPMI)—
1640 medium without arginine and lysine (Silantes, GmbH, Munich,
Germany) containing 10% fetal bovine serum dialysed using a
10-kDa cut-off membrane (Gibco, Life Technologies, Paisley, Scot-
land, UK), 2 mM alanyl-L-glutamine dipeptide (GlutaMAX, Gibco),
50 units/ml of penicillin (Gibco), 50 lg/ml of streptomycin (Gibco)
and 146 lg/ml light (12C6) L-lysine (Cambridge Isotope Labs,
Andover, MA, USA). Media were supplemented with either light
(Arg0, 12C6
14N4) or medium (Arg
6, 13C6
14N4) L-arginine (Cambridge
Isotope Labs) at a final concentration of 48 lg/ml at which Arg to
Pro conversion was not detected. To achieve a complete incorpora-
tion of the labelled amino acids, cells were maintained in culture for
seven population doublings (Fig EV5).
The pulsed SILAC strategy for protein turnover measurements
was previously described by Boisvert et al (2012). Briefly, suspen-
sion cultures containing equal numbers of unlabelled (Arg0) and
labelled (Arg6) cells were taken and the medium was removed by
centrifugation for 5 min at 350 g. Cell pellets were washed with PBS
and centrifuged for 5 min at 350 g. The unlabelled cells were then
suspended in light RPMI medium, whereas the medium labelled
(Arg6) cells were suspended in medium containing heavy Arg
(Arg10, 13C6
15N4) L-arginine. Following medium change, separate
starting cultures of 107 cells were cultured at a concentration of
2 × 105 cells/ml for periods of 0.5, 1.5, 4, 8, 12, 24 or 48 h, after
which cultures of 107 cells were collected by centrifugation. Follow-
ing two rounds of re-suspending in PBS and centrifugation at room
temperature, cell pellets were immediately frozen on dry ice and
stored at 80°C.
Proteins were isolated from cell pellets by three rounds of freez-
ing and thawing in 1 ml of 50 mM sodium phosphate buffer, pH
7.5, and cell debris was removed by a 10-min centrifugation at
13,200 g at 4°C. The protein concentration in the supernatants was
measured by the Bradford method, and for every time point
sample, an equal amount of medium/heavy labelled proteome
sample was mixed with the corresponding equivalent of light
control sample.
Cycloheximide pulse-chase experiments
100 lg/ml cycloheximide was added to Jurkat cells that were
cultured at a density of 180,000 cells/ml. A total of 3.46 × 106 cells
were harvested after 0, 0.5, 1.5, 4, 8, 12 or 24 h of treatment and
pelleted for 3 min at 800 g. Cells were lysed in 100 ll of RIPA buffer
(50 mM Tris–HCl pH 8.0, 150 mM NaCl, 1% NP-40) with protease
inhibitors added (Roche). All lysates were flash-frozen and stored at
80°C until further processing. Samples were thawed and centri-
fuged for 10 min at 13,200 g, followed by measurement of protein
content using the Bradford method. Forty micrograms of protein
material from each sample was separated by SDS–PAGE (4–12%
Criterion Bis-Tris gel, Bio-Rad), and protein levels were monitored
by Western blotting. The following antibodies were used: anti-lamin
B (NA12, Calbiochem), anti-securin (ab3305, Abcam), anti-b-
catenin (C2206, Sigma), anti-SYF2 (ab3610, Abcam), anti-GAPDH
(ab9484, Abcam), anti-actin (A2066, Sigma) and anti-a-tubulin
(T5168, Sigma). The intensity of bands was assessed using the
LICOR Odyssey software for Western Blot image processing.
To validate the proteomics-derived differential protein turnover
of dbTIS and aTIS proteoforms of MARE2 and AN32E, complete
cDNA clones were obtained from the ORFeome 7.1 collection (ID
4499) and I.M.A.G.E. (ID 3047915), respectively. Site-directed muta-
genesis (Stratagene, Agilent Technologies) by mutating ATG (Met)
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to TTG (Leu) codons was performed to analyse the expression of
selected proteoforms. (Mutagenised) constructs were subcloned into
the eukaryotic pEF-DEST51 expression vector (Gateway, Life Tech-
nologies) and transfected in HCT116 cells using Fugene HD
(Promega) at a 0.8/3/150,000 ratio of DNA [lg], Fugene HD [ll]
and number of cells. Cycloheximide pulse-chase experiments were
performed as described above for Jurkat cells, except that 150,000
HCT116 cells were harvested for every overexpressed construct and
time point analysed. Cells were lysed in 80 ll RIPA buffer, and
about 10 lg of total protein material was separated by SDS–PAGE.
Degradation of overexpressed proteoforms was monitored by
Western blotting using the anti-V5 antibody (R96025, Life Technolo-
gies) and compared to the turnover of stable proteins such as actin
(Schwanhausser et al, 2011).
N-terminal COFRADIC
The combined proteome mixtures were analysed by N-terminal
COFRADIC (Staes et al, 2011; Van Damme et al, 2011). In
summary, proteins are first blocked at their N-ends (a-amines) and
lysines (e-amines) by acetylation. After trypsin digestion, terminal
peptides are enriched for by means of SCX at low pH and by
applying two consecutive RP-HPLC separations. In the latter, any
remaining internal peptides and C-terminal peptides are shifted by
reaction of their free a-amino groups (new free a-amino groups
introduced by the action of trypsin) with 2,4,6-trinitrobenzenesul-
phonic acid (TNBS), thereby allowing for their segregation from
N-terminal peptides. Fractions enriched for N-terminal peptides are
subsequently analysed by means of LC-MS/MS. All steps of the
N-terminal COFRADIC analysis, including SCX enrichment, were
performed as described (Staes et al, 2011). More specifically, solid
guanidinium hydrochloride (Gu.HCl) was added to the proteome
mixtures to a final concentration of 4 M in order to denature all
proteins. Next, proteins were reduced and alkylated using TCEP and
iodoacetamide, respectively. Upon desalting of the S-alkylated
samples in 50 mM sodium phosphate (pH 8.0), primary free amines
were N-acetylated (no distinction between can be made between
in vivo Nt-free (and thus in vitro Nt-acetylated) and in vivo Nt-acety-
lated N-termini by adding sulfo-N-hydroxysuccinimide (NHS)
acetate (Pierce). Twice the molar excess of glycine over the NHS
ester was subsequently added to quench any non-reacted NHS-
acetate. Possible O-acetylation of Ser, Thr or Tyr residues was
reverted by adding hydroxylamine (Fluka) to the modified protein
mixtures. A final desalting step was performed in protein digestion
buffer (10 mM ammonium bicarbonate, pH 7.9), and the proteomes
were digested overnight at 37°C with sequencing-grade, modified
trypsin (Promega, Madison, WI, USA) (enzyme/substrate of 1/100,
w/w). Subsequent steps of the N-terminal COFRADIC analysis,
including SCX enrichment, were performed as described (Stes et al,
2014).
Following label swapping, one N-terminal COFRADIC analysis
was performed per time point (7 N-terminal COFRADIC analysis in
total). During the primary RP-HPLC separation of the actual N-term-
inal COFRADIC procedure, peptides were collected in 13 fractions of
4 min each. Next, 12 secondary fractions were collected per primary
fraction and pooled as described in Staes et al (2011), overall result-
ing in 36 samples for LC-MS/MS analysis per N-terminal COFRADIC
set-up.
LC-MS/MS analysis
LC-MS/MS analysis was performed using an Ultimate 3000 RSLC
nano HPLC (Dionex, Amsterdam, the Netherlands) in-line
connected to an LTQ Orbitrap Velos mass spectrometer (Thermo
Fisher Scientific, Bremen, Germany). The sample mixture was
loaded on a trapping column (made in-house, 100 lm
I.D. × 20 mm, 5-lm beads C18 Reprosil-HD, Dr. Maisch). After back
flushing from the trapping column, the sample was loaded on a
reverse-phase column (made in-house, 75 lm I.D. × 150 mm, 5-lm
beads C18 Reprosil-HD, Dr. Maisch). Peptides were loaded in
solvent A’ (0.1% trifluoroacetic acid, 2% acetonitrile (ACN)) and
separated with a linear gradient from 2% solvent A’’ (0.1% formic
acid) to 50% solvent B’ (0.1% formic acid and 80% ACN) at a flow
rate of 300 nl/min followed by a wash reaching 100% solvent B’.
The mass spectrometer was operated in data-dependent mode, auto-
matically switching between MS and MS/MS acquisition for the ten
most abundant peaks in a given MS spectrum. Full-scan MS spectra
were acquired in the Orbitrap at a target value of 1E6 with a resolu-
tion of 60,000. The 10 most intense ions were then isolated for frag-
mentation in the linear ion trap, with a dynamic exclusion of 20 s.
Peptides were fragmented after filling the ion trap at a target value
of 1E4 ion counts. Mascot Generic Files were created from the
MS/MS data in each LC run using the Mascot Distiller software
(version 2.4.2.0, Matrix Science, www.matrixscience.com/Dis-
tiller.html). To generate these MS/MS peak lists, grouping of spectra
was allowed with a maximum intermediate retention time of 30 s
and a maximum intermediate scan count of 5. Grouping was done
with a 0.005 Da precursor tolerance. A peak list was only generated
when the MS/MS spectrum contained more than 10 peaks. There
was no de-isotoping and the relative signal-to-noise limit was set at 2.
The generated MS/MS peak lists were searched with Mascot
using the Mascot Daemon interface (version 2.3.01, Matrix Science).
Searches were performed in the Swiss-Prot database with taxonomy
set to human (UniProtKB/Swiss-Prot database version 2011_08,
containing 20,244 human protein entries). The Mascot search
parameters were set as follows: acetylation at lysine side chains,
carbamidomethylation of cysteine and methionine oxidation to
methionine-sulfoxide were set as fixed modifications. Variable
modifications were acetylation of N-termini and pyroglutamate
formation of N-terminal glutamine (both at peptide level). Endopro-
teinase semi-Arg-C/P (semi-Arg-C specificity with Arg-Pro cleavage
allowed) was set as enzyme allowing for no missed cleavages. Mass
tolerance was set to 10 ppm on the precursor ion and to 0.5 Da on
fragment ions. Peptide charge was set to 1+, 2+, 3+ and instrument
setting was put to ESI-TRAP. Only peptides that scored above the
threshold score, set at 99% confidence, were withheld. The FDR
was estimated by searching a decoy database (a shuffled version of
the human Swiss-Prot database version 2011_08) and ranged from
0.32% to 2.27% for individual samples, with a global FDR of 1.18%
on the spectrum level.
Ribosome profiling
For ribosome profiling, Jurkat cells were grown in RPMI medium
(Gibco) supplemented with 10% fetal bovine serum, 2 mM alanyl-L-
glutamine dipeptide (GlutaMAX, Gibco), 50 units/ml penicillin and
50 lg/ml streptomycin at 37°C and 5% CO2. Cultures were treated
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with 50 lM lactimidomycin (LTM) (Ju et al, 2005; Schneider-
Poetsch et al, 2010) or 100 lg/ml cycloheximide (CHX) (Sigma,
USA) for 30 min at 37°C before cell harvest. Subsequently, cells
were collected by centrifugation (5 min at 300 g), rinsed with ice-
cold PBS and recovered again by centrifugation in the presence of
CHX. 108 cells were re-suspended in 1 ml ice-cold lysis buffer
[10 mM Tris–HCl, pH 7.4, 5 mM MgCl2, 100 mM KCl, 1% Triton
X-100, 2 mM dithiothreitol (DTT), 100 lg/ml CHX, 1× complete and
EDTA-free protease inhibitor cocktail (Roche)] (Guo et al, 2010).
Following 10 min of incubation on ice, samples were passed
through QIAshredder spin columns (Qiagen). The flow-through was
clarified by centrifugation for 10 min at 16,000 × g and 4°C. Six
hundred microlitres of the recovered supernatant was subjected to
RNase I (Life Technologies) digestion using 1000 U of enzyme.
Digestion of polysomes proceeded for 55 min at room temperature
and was stopped with SUPERase.In RNase Inhibitor (Life Technolo-
gies). Next, monosomes were recovered by ultracentrifugation at
75,000 rpm in a cooled TLA-120.2 rotor over a 1 M sucrose cushion
in 20 mM HEPES-KOH pH 7.4, 5 mM MgCl2, 100 mM KCl, 2 mM
DTT, 100 lg/ml CHX and 100 U/ml Superase.In. Subsequent steps
were performed as described by Ingolia et al (2011) with some
minor adjustments. RNA was extracted from the samples using a
heated acid phenol– chloroform– isoamyl alcohol (125:24:1)
procedure. Seventeen micrograms of RNA was subjected to
electrophoresis under denaturing conditions in 15% TBE-Urea poly-
acrylamide gel (Life Technologies). Ribosome-protected fragments
(RPFs) of 28–34 nucleotides were extracted from the gel in RNase-
free water for 10 min at 70°C and precipitated with 1/10 volume of
3 M sodium acetate pH 5.2, 1.5 ll GlycoBlue (Life Technologies)
and 1 volume of isopropanol overnight at 80°C. Following a
dephosphorylation reaction (end-repair) with 10 U of T4 polynu-
cleotide kinase (New England Biolabs), the RPFs were depleted of
ribosomal RNA contaminants using the Ribo-Zero Magnetic Gold Kit
(Illumina) according to the manufacturer’s protocol. Subsequently,
fragments were ligated to a 1.5 lg of Universal cloning linker using
200 U of T4 RNA ligase II (both New England Biolabs). The ligated
product was size-selected using denaturing gel electrophoresis and
purified from gel as described above. Subsequently, reverse tran-
scription (RT) was performed with 200 U of SuperScript III (Life
Technologies) according to Ingolia et al (2011), followed by a size
selection of the RT product (described above). Next, samples were
subjected to circular ligation using 100 U of CircLigase (Illumina)
and amplified by PCR using Phusion polymerase (New England
Biolabs) for 12 cycles of denaturation (10 s at 98°C), annealing
(10 s of 65°C) and elongation (5 s at 72°C) using primer pairs
compatible with the Illumina sequencing platform (Ingolia et al,
2011). The resulting ribosome profiling libraries of LTM- and CHX-
treated Jurkat cells were sequenced on a NextSeq 500 instrument
(Illumina) to yield 75-bp single-end reads.
Measurement of proteoform turnover
Arg-ending N-terminal peptides were selected that started at posi-
tion 1 or 2 (entries stored in the Swiss-Prot database) or derived
from alternative translation initiation at positions > 2) and which
complied with rules of iMet processing and Nt-acetylation (Van
Damme et al, 2014). For every unique N-terminus (unique
proteoform), SILAC ratios (M/L, H/L and H/M) calculated for the
highest scoring peptide identification were included in the analysis.
M/L and H/L ratios were normalised, according to equation (1):
if Mþ H ¼ L then M=Lþ H=L ¼ 1 (1)
where L, M and H denote light, medium and heavy isotope-labelled
peptide intensities.
M/L and H/L ratios were plotted in function of time as degrada-
tion and synthesis curves, respectively. The crossing over point
between the two curves corresponds to 50% protein turnover, see
Equation (2):
if M=LþH=L¼ 1ðEq. 1Þ and M=L¼ H=L then M=L¼ H=L¼ 1=2
(2)
Fifty per cent protein turnover was calculated as the crossing
point between protein degradation and synthesis curves for proteo-
forms quantified in at least three time points. We assumed that
protein degradation follows a first-order process. Therefore, an
exponential curve with one parameter (B) was fitted to M/L data
using the R software (version 0.98.739) and the turnover time was
calculated as follows:
M=L¼ e kdeg
ln(2)
tcc
 
t
; simplified toM=L¼ eBt; hence tturn¼ ln ð1=2Þ
B
(3)
where kdeg is the protein degradation constant; tcc, cell doubling
time; and tturn, turnover time.
Alternatively, the turnover time was approximated from linear
equations between two M/L and two H/L points lying on opposite
sides of the crossing point. We observed a very high correlation
between the exponential and the linear method (Pearson coefficient
of 0.98). Exponential curve fitting was used for protein turnover
determination if the quality of fit determined by the coefficient of
determination (R2) was at least 0.8. In other cases, turnover time
was calculated from the linear approximation, provided a
descending trend of M/L changes in time was observed. Turnover
measurements fulfilling criteria described above were regarded as
valid, while other turnover rates remained unassigned and were
excluded from analysis. Protein degradation constants were derived
from the parameter B (Equation 3) of individual M/L profiles, and
protein half-lives (t1/2) were calculated accordingly to equation (4):
t1=2 ¼ lnð1=2Þkdeg ¼
lnð1=2Þ
Bþ lnð2Þtcc
  (4)
Due to the constrains of equations (3) and (4), negative values of
kdeg were disregarded and protein half-lives estimated to be infinite
due to continuous cell divisions: t1/2 ≫ tcc ? t1/2  ∞.
Quantification of proteoform abundance
Per unique proteoform, spectral counts were averaged among all
time points whenever identified (using an arithmetical mean).
Normalised spectral abundance factor (NSAF) values (Paoletti et al,
2006) were calculated based on amino acid lengths of individual
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proteoforms. All proteoforms identified in at least one time point
were taken as the complete data set (Table EV1A).
Analysis of ribosome profiling data
Ribosome profiling (Ribo-Seq) performed in Jurkat cells treated with
CHX to study translation elongation and LTM to study translation
initiation were analysed using the PROTEOFORMER pipeline
(Crappe et al, 2015). PROTEOFORMER was used to perform the
quality control, mapping onto a reference genome, identification of
TIS and generation of a protein database.
The 30 adapter sequences were clipped using the fastx_clipper,
and reads shorter than 26 or longer than 34 nucleotides were
discarded for the Ribo-Seq-based TIS calling. The reads were first
mapped onto small nuclear RNA, tRNA and rRNA sequences to
eliminate contaminating reads. The remaining reads were subse-
quently mapped onto the human GRCh37 reference genome
(Ensembl annotation bundle 75) allowing for a maximum of two
mismatches along the entire read. Reads mapping to a maximum of
16 locations on the genome were allowed and retained for every
loci. All mapping steps were performed using STAR 2.4.0i. RPF
alignments were reduced to a specific position (the P-site nucleotide)
using an offset from the 50 end of the alignment based on the read
length (+12, +13 and +14, respectively, for alignment of ≤ 30 bases
long, 31–33 bases long and ≥ 34 bases long). Translation start sites
were identified by setting different parameter values for the different
TIS categories in the tool. A TIS was called at the Ensembl-annotated
start site if (i) it had a minimum read count of 5; (ii) the position
was a local maximum within a 7-nucleotide window (one codon
upstream and one codon downstream); (iii) the difference between
the LTM (foreground) and CHX (background) normalised ratio
(RLTM-CHX) within the window reached at least 0.01. A TIS was
called within the coding region of a transcript (downstream of anno-
tated start sites) if it had a minimum read count of 15 and RLTM-CHX
of 0.15. For TIS located at the 50UTR, 30UTR and other non-protein-
coding transcripts, the minimum read count was set to 10 with a
RLTM-CHX of 0.05.
We used the above settings to define translation initiation events
in Jurkat cells. Taking into consideration every annotated transcript
splice variant, all possible ORFs starting at the detected TIS sites
were in silico translated. The N-terminal peptides identified in our
pSILAC experiment (N = 2,578) were mapped onto the Ribo-Seq-
derived protein sequences allowing to associate peptides with ORFs
and their corresponding transcripts.
Analysis of translation initiation and splicing
To study the contribution of splicing and (alternative) translation
initiation to N-terminal proteoform expression, we mapped the
N-terminal peptides identified in our proteomics experiment onto
the human Swiss-Prot Isoform, UniProt TrEMBL, Ensembl human
protein sequences next the Ribo-Seq data from Jurkat cells. Further,
a comparison was made with Ribo-Seq data obtained from another
human cell line (HCT116 colorectal cancer cells, unpublished data).
In case of Ribo-Seq matching evidence, a peptide corresponding
to position 1 was assumed to be generated via translation initiation.
A peptide mapping at position 2 was considered a TIS only if the
first methionine was preceded by an alanine, cysteine, glycine,
proline, threonine or valine and therefore likely co-translationally
processed. We used the Jurkat data as reference (i) to retrieve
RLTM-CHX values for called TIS sites; (ii) to associate transcripts with
a normalised RPF read count (the normalised read count was calcu-
lated by summing all the reads that map across the transcript and
dividing by its length) and iii) to determine their exon coverage.
Since an N-terminal peptide might map to multiple transcripts,
additional information regarding the expression was provided for
every matching transcript to allow for a discrimination of transcripts
poorly supported by the Ribo-Seq data.
We further investigated whether a downstream peptide is point-
ing to a possible annotated splicing or alternative translation event
by checking whether this peptide matched the N-terminal protein
sequence previously reported in the protein databases: Ensembl,
Swiss-Prot Isoform or UniProt TrEMBL protein sequences. A
peptide was considered as a possible N-terminus of a splice variant
if it mapped at position 1 or 2 to a given sequence in Ensembl or
Swiss-Prot Isoform databases. Further, we qualified the Ensembl-
derived evidence of splicing as either poor (less likely) or good
(likely) splicing events. A downstream peptide was considered to
be supported by a likely splicing event if any of the Ensembl
protein sequences associated with the peptide had a transcript
support level less than or equal to three (with one being the high-
est rank). If none of the protein sequences associated with the
peptide had a transcript support level less than three, it was
considered as a poorly supported splicing event or not applicable if
there was no transcript support level assigned to any of the valid
transcripts. For N-terminal peptides matching an N-terminus of a
Swiss-Prot Isoform sequence, we further retrieved the information
if this protein isoform is generated via splicing or alternative trans-
lation initiation. The above-mentioned data are presented in
Table EV1C.
Analysis of proteoform turnover rates in
macromolecular complexes
To investigate the dynamic properties of macromolecular complex
substituents, protein turnover times were mapped to members of
human protein complexes defined by the CORUM database (core set
of 1,343 human complexes, Ruepp et al, 2008). Only Swiss-Prot-
annotated proteoforms (dbTIS) with the most plausible iMet
processing status (Van Damme et al, 2011) and high-quality turn-
over measurement were considered (Arnesen et al, 2009; Van
Damme et al, 2011). Absolute differences in turnover were calcu-
lated pairwise between all members of a complex. Subsequently,
one-sided Mann–Whitney U-test at a 95% confidence interval (R,
wilcoxon.test, stats package) was applied to detect proteins with
significantly higher absolute differences than the remaining
members of a complex.
Gene ontology enrichment analysis
Swiss-Prot accessions of the 1,894 proteoforms with high-quality
measurement of stability of one representative N-terminal proteo-
form were ranked based on their corresponding turnover values.
Subsequently, an enrichment analysis of GO terms was performed
using GOrilla (http://cbl-gorilla.cs.technion.ac.il/; Eden et al, 2009)
using the “single ranked list of genes” option. Duplicate accessions
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were removed keeping the highest ranking instance per accession.
The enrichment P-values were computed using mHG (minimal
Hyper Geometric) statistics and corrected for multiple testing using
the Benjamini and Hochberg method giving the FDR q-values. GO
terms enriched in stable or unstable proteins with FDR q-values
≤ 0.05 were subsequently summarised using REViGO (Supek et al,
2011). Redundant GO terms were removed and the remaining
terms visualised in bar charts according to their significance
(log10(q-value)). Analogously, we performed an enrichment analy-
sis of GO terms in aTIS vs. dbTIS proteoforms using the GOrilla
“target and background” option.
Prediction of protein intrinsic disorder
Canonical protein sequences identified in at least three time points
(1,972 proteoforms) were retrieved and adjusted to start at the
initiating residue of the N-terminal peptide identified. Of these prote-
oforms, the percentage of intrinsically disorder was predicted using
RAPID (http://biomine-ws.ece.ualberta.ca/RAPID/index.php; Yan
et al, 2013) which implements the IUPred algorithms (Dosztanyi
et al, 2005a,b).
Hydropathy of protein N-termini
The grand average of hydropathy (GRAVY) was calculated for the
2- and 10-amino acid-long N-terminal sequence of every proteoform
(1,894 proteoforms) at http://www.gravy-calculator.de/. Increasing
positive score indicated greater hydrophobicity. The calculation was
based on the sum of hydropathy values of amino acids in Kyte–
Doolittle scale (Kyte & Doolittle, 1982), divided by the number of
residues. Correlation between GRAVY values and turnover times
was estimated using Pearson and Spearman correlation coefficients.
Statistical analysis of turnover, abundance and disorder of aTIS
versus dbTIS
Differences in turnover, abundance and disorder values between
aTIS and dbTIS groups were measured for paired dbTIS-aTIS data
using a Wilcoxon signed-rank one-sided test for paired samples (R,
stats package) and independently between the whole aTIS and
dbTIS groups using a Kruskal–Wallis test for difference in
distribution (R, stats package), multiple comparison test after
Kruskal–Wallis (R, pgirmess package) and Mann–Whitney one-
sided test for independent samples. All analyses were performed in
R at P ≤ 0.05 significance.
Category enrichment analysis in turnover, disorder and
abundance data
1D enrichment analysis of Pfam, KEGG, GO slim and other cate-
gories was performed using the Perseus software (Cox & Mann,
2012) at P ≤ 0.01 significance with a two-sided test with Benjamini–
Hochberg FDR correction. Turnover, disorder and abundance values
corresponding to each categorical term were tested for deviations
from the complete distribution, and a preference for larger or
smaller values was assessed independently for every variable.
Correlation of turnover, disorder and abundance values was
assessed using Spearman rank correlation.
Relation between protein turnover and N-terminal amino
acid composition
All proteoforms with measured turnover rates (including proteo-
forms with alternative iMet processing; 1,941 in total) were cate-
gorised according to the identity of their utmost N-terminal
residues. Additionally, N-termini susceptible to iMet processing
were further categorised as either Met retaining or Met cleaved. The
general impact of N-terminal residues and iMet processing (categori-
cal variables) on protein turnover was assessed by a Kruskal–Wallis
rank sum test (R, stats package). A subsequent multiple comparison
test for Kruskal–Wallis (R, pgirmess package) and pairwise
Wilcoxon rank sum test (without correction for multiple testing; R,
stats package) allowed to indicate the most deviating subgroups
(with P < 0.05).
Data availability
MS/MS data was converted using PRIDE Converter (Barsnes et al,
2009) and is available through the PRIDE database (Martens et al,
2005) with the data set identifier PXD002091 and DOI: 10.6019/
PXD002091.
Ribo-Seq sequencing data has been deposited in NCBI’s Gene
Expression Omnibus (Edgar et al, 2002) and is accessible through
GEO Series accession number GSE74279 (http://www.ncbi.nlm.nih.
gov/geo/query/ acc.cgi?acc=GSE74279).
Expanded View for this article is available online.
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